Xtant Medical Holdings, Inc.
XTNT
$0.51
$0.0234.72%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 31.51M | 27.94M | 29.94M | 27.87M | 28.11M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 31.51M | 27.94M | 29.94M | 27.87M | 28.11M |
| Cost of Revenue | 15.49M | 11.63M | 11.36M | 10.57M | 10.97M |
| Gross Profit | 16.02M | 16.31M | 18.58M | 17.30M | 17.14M |
| SG&A Expenses | 17.38M | 19.38M | 20.89M | 20.25M | 20.45M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 33.40M | 31.71M | 32.89M | 31.34M | 31.91M |
| Operating Income | -1.88M | -3.78M | -2.95M | -3.47M | -3.81M |
| Income Before Tax | -3.14M | -4.96M | -3.83M | -4.33M | -3.73M |
| Income Tax Expenses | 21.00K | 62.00K | 36.00K | 68.00K | 577.00K |
| Earnings from Continuing Operations | -3.17M | -5.02M | -3.86M | -4.40M | -4.30M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.17M | -5.02M | -3.86M | -4.40M | -4.30M |
| EBIT | -1.88M | -3.78M | -2.95M | -3.47M | -3.81M |
| EBITDA | -734.00K | -2.70M | -1.95M | -2.47M | -2.79M |
| EPS Basic | -0.02 | -0.04 | -0.03 | -0.03 | -0.03 |
| Normalized Basic EPS | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 |
| EPS Diluted | -0.02 | -0.04 | -0.03 | -0.03 | -0.03 |
| Normalized Diluted EPS | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 158.25M | 135.10M | 130.27M | 130.20M | 130.02M |
| Average Diluted Shares Outstanding | 158.25M | 135.10M | 130.27M | 130.20M | 130.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
